-
Contains 12 relevant, practice-oriented topics including HFrEF and COVID-19: unmasking health inequities during a pandemic; our goals for prevention versus treating HFrEF with modern tech; the economic burden of HFrEF: living longer but poorer; obesity in heart failure; the value of cardiopulmonary exercise testing in ambulatory HFrEF; and more.�
-
Provides in-depth clinical reviews on heart failure with reduced ejection fraction, offering actionable insights for clinical practice.�
-
Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.�
Please Note: This is an On Demand product, delivery may take up to 11 working days after payment has been received.
Table of Contents
Heart Failure with Reduced Ejection Fraction and COVID-19, when the Sick Get Sicker: Unmasking Racial and Ethnic Inequities During a PandemicThe Economic Burden of Heart Failure with Reduced Ejection Fraction: Living Longer but Poorer?
Sequencing Quadruple Therapy for Heart Failure with Reduced Ejection Fraction: Does It Really Matter?
Frailty and Its Implications in Heart Failure with Reduced Ejection Fraction: Impact on Prognosis and Treatment
Obesity in Heart Failure with Reduced Ejection Fraction: Time to Address the Elephant in the Room
The Uncertain Benefit from Implantable Cardioverter-Defibrillators in Nonischemic Cardiomyopathy: How to Guide Clinical Decision-Making?
The War Against Heart Failure Hospitalizations: Remote Monitoring and the Case for Expanding Criteria
Secondary Mitral Regurgitation and Transcatheter Mitral Valve Therapies: Do They Have a Role in Advanced Heart Failure with Reduced Ejection Fraction?
Guide to Temporary Mechanical Support in Cardiogenic Shock: Choosing Wisely
When all Else Fails, Try This: The HeartMate III Left Ventricle Assist Device
